How to deal with the increased demand for drugs in the Corona crisis?
The pharmaceutical industry is particularly challenged in the corona crisis – also from an ethical point of view. Self-control is needed to prevent the best bidder principle for drugs. In addition, politics must reform competition rules, says Markus Scholz (Head of Center for Corporate Governance & Business Ethics) in a guest commentary on science.orf.at.
See the guest commentary by Markus Scholz here.